Phase Ib trial of PHE 377 in male volunteers.
Phase of Trial: Phase I
Latest Information Update: 24 May 2011
At a glance
- Drugs PHE 377 (Primary)
- Indications Neuropathic pain
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 24 May 2011 Planned End Date changed to 1 Aug 2011.
- 24 May 2011 New trial record